课题基金 / 基金详情

Regulation of natural killer cell-mediated immune response in breast cancer

Regulation of natural killer cell-mediated immune response in breast cancer
自然杀伤细胞介导的乳腺癌免疫反应的调节
批准号:
494926
负责人:
Rahim Mir Munir Ahmed
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-09-01 至 2024-09-01

项目摘要

项目成果

Rahim Mir Munir Ahmed的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Natural killer (NK) cell is a type of immune cell that constitutes the body's first line of defense against infections and cancers. NK cells can eliminate cancer cells by cell lysis. They can also modulate the activity of other immune cells to promote ant
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunosurveillance of breast cancer by innate immune cells
  • 批准号:
    453386
  • 项目类别:
    Operating Grants
  • 资助金额:
    $4.37万
  • 财政年份:
    2021
  • 负责人:
    Rahim Mir Munir Ahmed
  • 依托单位:
海外基金